16-30 of 128
Dana Rizk, MD
Suzuki Yusuke, MD, PhD
Dana Rizk, MD
Hong Zhang
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
MinuteCE®The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
Richard Lafayette, MD, FACP
Beyond RAASi and Approved Therapies: The Unmet Needs in IgAN
MinuteCE®Beyond RAASi and Approved Therapies: The Unmet Needs in IgAN
Hong Zhang
Emerging Therapies in IgAN: Who Could Benefit the Most?
MinuteCE®Emerging Therapies in IgAN: Who Could Benefit the Most?
Richard Lafayette, MD, FACP
Hong Zhang
Richard Lafayette, MD, FACP
Dana Rizk, MD
Hong Zhang
Suzuki Yusuke, MD, PhD
- advertisement
Inside the IgAN Clinic: Shared Decision-Making Into Practice
CME/CEInside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CECase-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CETargeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Richard E. Pratley, MD
David Cherney, MD, PhD
prof. Hiddo Heerspink
A New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion
CME/CEA New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion
Andrew S. Bomback, MD, MPH
Kelly B. Chen, MSN, AGACNP-BC
Duvuru Geetha, MD
Nephrology at the Helm—Advancing Timely CKD Care Through Cross-Specialty Collaboration
CME/CENephrology at the Helm—Advancing Timely CKD Care Through Cross-Specialty Collaboration
Kelly B. Chen, MSN, AGACNP-BC
Chuck Vega, MD, FAAFP
Jay B. Wish, MD
- advertisement
IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
CME/CEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Jörg Latus, MD
Jürgen Floege, MD
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CEEngaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Scott Solomon, MD
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CENavigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
Roy F. Chemaly, MD, MPH, FIDSA, FACP
Atul Humar, MD, FRCPC, FAST
